New and Potential Treatments for Atopic Dermatitis: Biologicals and Small MoleculesAtopic dermatitisBiologicalsDupilumabEczemaSmall moleculesTreatmentAn update on new therapies currently approved or potentially useful in the future for the management of patients suffering moderate-to-severe atopic dermatitis. ...
New treatments for atopic dermatitis.Editorial. Comments on the use of tacrolimus and pimecrolimus to treat atopic dermatitis in children. Lack of clinical trials to test and compare treatments; Comparison of tacrolimus and pimecrolimus to topical corticosteroids; Safety of the drugs.Williams...
It is explicitly not our intention to compare novel treatments with their specific advantages and disadvantages with existing ones, because this is best done by experts in a therapeutic area. Similarly, we do not discuss drug pricing for novel treatments. Such discussion can only be meaningful base...
We strangely don’t yet know what causes cradle cap in babies but what we do know is this: it cannot be spread from one baby to another.3Sometimes cradle cap in babies can be confused withbaby eczemaor atopic dermatitis. A major difference between these conditions is that atopic dermatitis ...
Galderma understands the need for specifically designed treatments and personalized skincare regimes. At the EADV this year, Galderma, along with key opinion leaders, will be challenging the existing paradigms on sensitive skin and challenging the co...
Since 1987, the Mectizan Donation Program has approved 1.4 billion treatments for the control and elimination of onchocerciasis, and 1.2 billion treatments (administered with albendazole, donated by GlaxoSmithKline) for the control and elimination of lymphatic filariasis (http://www.mectizan.org/resources...
Galderma understands the need for specifically designed treatments and personalized skincare regimes. At the EADV this year, Galderma, along with key opinion leaders, will be challenging the existing paradigms on sensitive skin and challenging the community on whether it should be considere...
New treatments for atopic dermatitisdoi:10.1016/S0889-8561(03)00074-2Lynda C SchneiderImmunology and Allergy Clinics of North America
Translation of the immune response and intracellular signaling pathways for dermatological conditions Dermatological therapy is enhancing their potential field of action based on the new treatments using biological antibodies and new small oral molecules applied for inflammatory diseases, cutaneous cancer, and...
Historically, systemic treatments for atopic dermatitis (AD) primarily consisted of immunosuppressive agents such as corticosteroids and Disease Modifying Antirheumatic Drugs (DMARDS), which provided symptomatic relief but often had long-term adverse effects. Newer treatments have shown significant efficacy ...